CD8A and neoplasm: Chemokines can serve pro- or anti-tumor functions, with the chemokines CXCL9 and CXCL10, ligands for CXCR3, being of the most interest in the anti-tumor category due to their ability to attract effector CD8+ and CD4+ T cells (43).